-
1
-
-
34447255182
-
A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets
-
Pasvolsky R, Feigelson SW, Kilic SS, et al. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets. J Exp Med 2007; 204: 1571-1582.
-
(2007)
J Exp Med
, vol.204
, pp. 1571-1582
-
-
Pasvolsky, R.1
Feigelson, S.W.2
Kilic, S.S.3
-
2
-
-
59449094432
-
The clinical spectrum of Leukocyte Adhesion Deficiency (LAD) III due to defective CalDAG-GEFI
-
Kilic SS, Etzioni A. The clinical spectrum of Leukocyte Adhesion Deficiency (LAD) III due to defective CalDAG-GEFI. J Clin Immunol 2009; 29: 117-122.
-
(2009)
J Clin Immunol
, vol.29
, pp. 117-122
-
-
Kilic, S.S.1
Etzioni, A.2
-
3
-
-
4644221351
-
Cal-DAG-GEFI integrates signaling for platelet aggregation and thrombus formation
-
Crittenden JR, Bergmeier W, Zhang Y, et al. Cal-DAG-GEFI integrates signaling for platelet aggregation and thrombus formation. Nature Medicine 2004; 10: 982-986.
-
(2004)
Nature Medicine
, vol.10
, pp. 982-986
-
-
Crittenden, J.R.1
Bergmeier, W.2
Zhang, Y.3
-
4
-
-
34249863368
-
Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III
-
Bergmeier W, Goerge T, Wang HW, et al. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III. J Clin Invest 2007; 117: 1699-1707.
-
(2007)
J Clin Invest
, vol.117
, pp. 1699-1707
-
-
Bergmeier, W.1
Goerge, T.2
Wang, H.W.3
-
5
-
-
34447532047
-
Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets
-
Boudreaux MK, Catalfamo JL, Klok M. Calcium-diacylglycerol guanine nucleotide exchange factor I gene mutations associated with loss of function in canine platelets. Translational Res 2007; 150: 81-92.
-
(2007)
Translational Res
, vol.150
, pp. 81-92
-
-
Boudreaux, M.K.1
Catalfamo, J.L.2
Klok, M.3
-
6
-
-
37149013574
-
Calcium diacylglycerol guanine nucleotide exchange factor I (CalDAG-GEFI) gene mutations in a thrombopathic Simmental calf
-
Boudreaux MK, Schmutz S, French P. Calcium diacylglycerol guanine nucleotide exchange factor I (CalDAG-GEFI) gene mutations in a thrombopathic Simmental calf. Vet Pathol 2007; 44: 932-945.
-
(2007)
Vet Pathol
, vol.44
, pp. 932-945
-
-
Boudreaux, M.K.1
Schmutz, S.2
French, P.3
-
7
-
-
66549121768
-
LAD1/variant syndrome is caused by mutations in FERMT3
-
Kuijpers TW, van de Vijver E, Weterman MAJ, et al. LAD1/variant syndrome is caused by mutations in FERMT3. Blood 2009; 113: 4740-4746.
-
(2009)
Blood
, vol.113
, pp. 4740-4746
-
-
Kuijpers, T.W.1
van de Vijver, E.2
Weterman, M.A.J.3
-
8
-
-
61949086409
-
Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation
-
Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nature Med 2009; 15: 306-312.
-
(2009)
Nature Med
, vol.15
, pp. 306-312
-
-
Svensson, L.1
Howarth, K.2
McDowall, A.3
-
9
-
-
61949240364
-
A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans
-
Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nature Medicine 2009; 15: 313-318.
-
(2009)
Nature Medicine
, vol.15
, pp. 313-318
-
-
Malinin, N.L.1
Zhang, L.2
Choi, J.3
-
10
-
-
40449133970
-
Kindlin-3 is essential for integrin activation and platelet aggregation
-
Moser M, Nieswandt B, Ussar S, et al. Kindlin-3 is essential for integrin activation and platelet aggregation. Nature Medicine 2008; 14: 325-330.
-
(2008)
Nature Medicine
, vol.14
, pp. 325-330
-
-
Moser, M.1
Nieswandt, B.2
Ussar, S.3
-
11
-
-
61949352480
-
Kindlin-3 is required for β2 integrin-mediated leukocyte adhesion to endothelial cells
-
Moser M, Bauer M, Schmid S, et al. Kindlin-3 is required for β2 integrin-mediated leukocyte adhesion to endothelial cells. Nature Med 2009; 15: 300-305.
-
(2009)
Nature Med
, vol.15
, pp. 300-305
-
-
Moser, M.1
Bauer, M.2
Schmid, S.3
|